{"id":"NCT02136134","sponsor":"Janssen Research & Development, LLC","briefTitle":"Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma","officialTitle":"Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-08-15","primaryCompletion":"2016-01-11","completion":"2024-01-10","firstPosted":"2014-05-12","resultsPosted":"2017-02-10","lastUpdate":"2025-08-29"},"enrollment":498,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Daratumumab","otherNames":[]},{"type":"DRUG","name":"VELCADE (Bortezomib)","otherNames":["VELCADE"]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]}],"arms":[{"label":"Daratumumab+VELCADE+dexamethasone","type":"EXPERIMENTAL"},{"label":"VELCADE+dexamethasone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the effects of administration of daratumumab when combined with VELCADE (bortezomib) and dexamethasone compared with bortezomib and dexamethasone alone, for participants with relapsed or refractory multiple myeloma.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"From the date of randomization to either progressive disease or death, whichever occurred first (approximately 1 year 4 months)","effectByArm":[{"arm":"Bortezomib + Dexamethasone (Vd)","deltaMin":7.16,"sd":null},{"arm":"Daratumumab + Bortezomib and Dexamethasone (DVd)","deltaMin":null,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":105,"countries":["United States","Australia","Brazil","Czechia","Germany","Hungary","Mexico","Netherlands","Poland","Russia","South Korea","Spain","Sweden","Turkey (TÃ¼rkiye)","Ukraine"]},"refs":{"pmids":["39229471","38048391","36413710","35876974","34289038","33513030","32819447","31221782","27557302"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":81,"n":237},"commonTop":["Thrombocytopenia","Peripheral sensory neuropathy","Anaemia","Diarrhoea","Upper respiratory tract infection"]}}